Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear

Circulation Research

Volumn 86, Issue 12, 2000, Pages 1245-1251

  Salmi, Marko ^a   Tohka, Sami ^a   Jalkanen, Sirpa ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Adhesion; Cell trafficking; Enzymatic activity; Leukocyte endothelial cell interactions; Recruitment

Indexed keywords

VASCULAR ADHESION PROTEIN 1;

ARTICLE; BINDING COMPETITION; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKOCYTE ADHERENCE; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; RAJI CELL; SHEAR STRESS; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0034705486     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.12.1245     Document Type: Article

References (20)

1. Salmi M, Jalkanen S. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol. 1997;64: 139-218.
2. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
3. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272:60-66.
4. Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science. 1992;257:1407-1409.
5. Girard J-P, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today. 1995;16: 449-457.
6. Lyles GA. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. Int J Biochem Cell Biol. 1996;28:259-274.
7. Klinman JP, Mu D. Quinoenzymes in biology. Annu Rev Biochem. 1994;63:299-344.
8. Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S. Cloning of vascular adhesion protein-1 reveals a novel multifunctional adhesion molecule. J Exp Med. 1998;188:17-27.
9. Stamper HB Jr, Woodruff JJ. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J Exp Med. 1976;144:828-833.
10. Ise Y, Yamaguchi K, Sato K, Yamamura Y, Kitamura F, Tamatani T, Miyasaka M. Molecular mechanisms underlying lymphocyte recirculation, I: functional, phenotypical and morphological characterization of high endothelial cells cultured in vitro. Eur J Immunol. 1988;18: 1235-1244.
11. Salmi M, Granfors K, Leirisalo-Repo M, Hämäläinen M, MacDermott R, Leino R, Havia T, Jalkanen S. Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues. Proc Natl Acad Sci U S A. 1992;89:11436-11440.
12. Salmi M, Tohka S, Berg EL, Butcher EC, Jalkanen S. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J Exp Med. 1997;186:589-600.
13. Tu L, Delahunty MD, Ding H, Luscinskas FW, Tedder TF. The cutaneous lymphocyte antigen is an essential component of the L-selectin ligand induced on human vascular endothelial cells. J Exp Med. 1999;189: 241-252.
14. Majuri ML, Rabina J, Niittymäki J, Tiisala S, Mattila P, Aavik E, Miyasaka M, Renkonen O, Renkonen R. High endothelial cells synthesize and degrade sLex: putative implications for L-selectin-dependent recognition. FEBS Lett. 1999;455:97-100.
15. Arvilommi A-M, Salmi M, Jalkanen S. Organ-selective regulation of vascular adhesion protein-1 expression in man. Eur J Immunol. 1997;27: 1794-1800.
16. Kurkijärvi R, Adams DH, Leino R, Möttönen T, Jalkanen S, Salmi M. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol. 1998; 161:1549-1557.
17. Picker LJ, Nakache M, Butcher EC. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol. 1989;109:927-937.
18. Lesley J, Kincade PW, Hyman R. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur J Immunol. 1993;23:1902-1909.
19. Galandrini R, De Maria R, Piccoli M, Frati L, Santoni A. CD44 triggering enhances human NK cell cytotoxic functions. J Immunol. 1994;153: 4399-4407.
20. Salminen TA, Smith DJ, Jalkanen S, Johnson MS. Structural model of the catalytic domain of an enzyme with cell adhesion activity: human vascular adhesion protein-1 (HVAP-1) D4 domain is an amine oxidase. Protein Eng. 1998;11:1195-1204.